Our Science

Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Existing data in the field of immunometabolism support the key hypothesis that it is possible to manipulate intracellular metabolic pathways in specific cells to alter their activity and bring about a disease-modifying effect.

Given the emerging nature of the field, Sitryx scientists are currently exploring multiple metabolic pathways within immune cells to identify potential ‘druggable’ targets for the development of groundbreaking new therapies for treating cancer and inflammation.

Cells
Cells